Article ; Online: A systematic review of randomised controlled trials on topical nasal steroids.
2024 Volume 44, Issue 2, Page(s) 71–75
Abstract: Introduction: Intranasal corticosteroids (INCs) are the first line of therapy for chronic sinonasal conditions such as rhinitis and rhinosinusitis. Among these, one of the most frequently used is beclomethasone dipropionate (BDP). Over the years many ... ...
Abstract | Introduction: Intranasal corticosteroids (INCs) are the first line of therapy for chronic sinonasal conditions such as rhinitis and rhinosinusitis. Among these, one of the most frequently used is beclomethasone dipropionate (BDP). Over the years many studies have evaluated the efficacy of BDP as part of therapy for chronic rhinosinusitis (CRS) and allergic rhinitis (AR) along with nasal washes, which seems to be very well tolerated. Objective: To analyse the data in the literature regarding the various therapeutic regimens of BDP in different sinonasal disease and their efficacy and tolerability. Materials and methods: Using different search engines, the posology, efficacy, and tolerability of BDP were reviewed and a total of 64 full-length articles were examined for eligibility. After applying inclusion and exclusion criteria, 4 articles were reviewed. Results: BDP is among the group of INCs with significant improvement of nasal symptoms and has good efficacy and safety. Conclusions: BDP nasal spray is one of the most frequently prescribed INC for rhinitis and rhinosinusitis. Treatment with BDP resulted in significant and clinically meaningful improvements in nasal symptoms associated with AR and CRS. BDP is well tolerated, and the safety profile is similar to that of placebo in most patients. These results, in conjunction with the significant benefit reported in subjects with CRS and AR, provide convincing evidence of the overall effectiveness of BDP for the treatment of the full spectrum of sinonasal disease. |
---|---|
MeSH term(s) | Humans ; Randomized Controlled Trials as Topic ; Administration, Intranasal ; Rhinitis/drug therapy ; Sinusitis/drug therapy ; Beclomethasone/administration & dosage ; Beclomethasone/therapeutic use ; Adrenal Cortex Hormones/administration & dosage ; Adrenal Cortex Hormones/therapeutic use ; Glucocorticoids/administration & dosage ; Glucocorticoids/therapeutic use ; Chronic Disease |
Chemical Substances | Beclomethasone (KGZ1SLC28Z) ; Adrenal Cortex Hormones ; Glucocorticoids |
Language | English |
Publishing date | 2024-04-23 |
Publishing country | Italy |
Document type | Journal Article ; Systematic Review ; Review |
ZDB-ID | 604898-5 |
ISSN | 1827-675X ; 0392-100X |
ISSN (online) | 1827-675X |
ISSN | 0392-100X |
DOI | 10.14639/0392-100X-N2745 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.B 2608: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.